A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies
Acta Biomaterialia · 2025
DOI: 10.1016/j.actbio.2024.11.024 ↗Kurz gefasst
Fachartikel in der Zeitschrift Acta Biomaterialia, 2025. Verfasst von Zhelong Zhang und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatmen…. Hauptthemen laut MEDLINE: Camptothecin, Sorafenib, Nanoparticles. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 43 Literaturangaben. Gefördert von: National Natural Science Foundation of China, National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers, Shandong Province Natural Science Foundation.
Abstract (Originalsprache)
Despite significant advancements in anticancer nanotherapeutics, the efficient encapsulation of multiple therapeutic modalities within single nanocarriers remains challenging due to the complex requirements of supramolecular self-assembly and/or chemical modification. These intricate synthesis procedures often impede the clinical translation of promising nanomedicines. In this study, we introduce a cost-effective and straightforward self-assembling cytotoxic nanotherapeutic strategy that enables the noncovalent incorporation of water-insoluble anticancer molecular inhibitors with high drug loading. This was achieved through the lipid conjugation of camptothecin, enabling nanoassembly in aqueous solutions devoid of excipients. These nanoassemblies were further developed into nanovehicles capable of encapsulating a high capacity of structurally diverse cargos, including molecularly targeted agents. Notably, nanoassemblies composed of linoleic acid-conjugated camptothecin and sorafenib demonstrated stability and sustained release of their payloads. The combination nanoparticles exhibited synergistic effects and effectively overcame ABCG2-mediated drug resistance in hepatocellular carcinoma (HCC). Systemic administration of these nanotherapeutics led to sustained tumor growth inhibition in various HCC xenograft-bearing mouse models, including a chemically induced orthotopic HCC model. This innovative supramolecular assembly strategy, which allows a single vehicle to deliver multimodal therapies, shows promise in overcoming drug resistance in human HCC and could be adapted for the development of other injectable nanomedicines, warranting further investigation. STATEMENT OF SIGNIFICANCE: This study advances anticancer nanotherapy by developing a simple and cost-effective self-assembling strategy that enables high loading of multiple water-insoluble chemotherapeutics. Using lipid-conjugated camptothecin, we created stable nanoassemblies capable of synergistically delivering diverse molecularly targeted agents. This combinatory platform effectively overcame therapeutic resistance and demonstrated sustained tumor inhibition in hepatocellular carcinoma-bearing mouse models. This new self-assembling cytotoxic nanotherapeutic strategy has potential applications for the development of other injectable nanomedicines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital, NHC Key Laboratory of Combined Multi-Organ Transplantation, Collaborative Innovation Center for Diagnosis and Treatment of Infectious Diseases, State Key Laboratory for Diagnosis and Treat…
- Department of Medical Oncology, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, Zhejiang 310016, China. Electronic address: cxn@zju.edu.cn.
Förderung
- National Natural Science Foundation of China
- National Natural Science Foundation of China-Shandong Joint Fund for Marine Science Research Centers
- Shandong Province Natural Science Foundation
- Zhejiang University
- Natural Science Foundation of Zhejiang Province
Zitieren
APA
Zhang, Z., Zhu, H., Xie, K., Lu, J., Chen, X., & Wang, H. (2025). A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies. Acta Biomaterialia. https://doi.org/10.1016/j.actbio.2024.11.024
Vancouver
Zhang Z, Zhu H, Xie K, Lu J, Chen X, Wang H. A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies. Acta Biomaterialia. 2025. doi:10.1016/j.actbio.2024.11.024
BibTeX
@article{Zhang2025,
author = {Zhang, Zhelong and Zhu, Hengyan and Xie, Ke and Lu, Jiani and Chen, Xiaona and Wang, Hangxiang},
title = {A self-assembling cytotoxic nanotherapeutic strategy for high drug loading and synergistic delivery of molecularly targeted therapies},
journal = {Acta Biomaterialia},
year = {2025},
doi = {10.1016/j.actbio.2024.11.024}
}
EUVIMED